These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23991931)
1. High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future. Isidori A; Piccaluga PP; Loscocco F; Guiducci B; Barulli S; Ricciardi T; Picardi P; Visani G Expert Rev Hematol; 2013 Aug; 6(4):451-64. PubMed ID: 23991931 [TBL] [Abstract][Full Text] [Related]
2. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]
3. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma. Sureda A Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630 [TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
8. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases]. Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021 [TBL] [Abstract][Full Text] [Related]
9. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation. Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284 [TBL] [Abstract][Full Text] [Related]
10. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
11. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A; Forman SJ Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658 [TBL] [Abstract][Full Text] [Related]
12. Stem cell transplantation in Hodgkin lymphoma. Reddy NM; Perales MA Hematol Oncol Clin North Am; 2014 Dec; 28(6):1097-112. PubMed ID: 25459181 [TBL] [Abstract][Full Text] [Related]
13. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Laport GF; Williams SF Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600 [TBL] [Abstract][Full Text] [Related]
14. Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphoma. Colpo A; Hochberg E; Chen YB Oncologist; 2012; 17(1):80-90. PubMed ID: 22210089 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle. Brice P; Bouabdallah R; Moreau P; Divine M; André M; Aoudjane M; Fleury J; Anglaret B; Baruchel A; Sensebe L; Colombat P Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251 [TBL] [Abstract][Full Text] [Related]
17. [Role of autologous stem cell transplantation in the treatment of Hodgkin's lymphoma]. Barillari G; Fanin R; Biffoni F Recenti Prog Med; 1998 Feb; 89(2):87-98. PubMed ID: 9558912 [TBL] [Abstract][Full Text] [Related]
18. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Brice P; Marolleau JP; Dombret H; Lepage E; Baruchel A; Adam M; Miclea JM; Sitthy X; Gisselbrecht C Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162 [TBL] [Abstract][Full Text] [Related]
19. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma. Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510 [TBL] [Abstract][Full Text] [Related]
20. Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents. Daw S; Wynn R; Wallace H Br J Haematol; 2011 Feb; 152(3):249-60. PubMed ID: 21133886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]